glp-1 afib GLP‑1 Therapy Improves Atrial Fibrillation Outcomes After Catheter Ablation, Miller School Study Finds GLP-1 Agonists in Cardiovascular Diseases:

Tirzepatide (Mounjaro) , a dual GIP/GLP-1 receptor agonist, has been under NICE appraisal for weight management

The choice often comes down to personal needs, lifestyle, and insurance coverage

For men with borderline low testosterone who are considering both TRT and weight loss, Retatrutide alone may be sufficient to restore levels to normal range without exogenous testosterone supplementation

Here we present the antioxidant GSH as a potential unexplored way for further investigation as intervention for COVID-19, since GSH levels are correlated with disease severity and lung damage supporting the participation of GSH in disease outcome (Kryukov et al., 2021

Ive seen mamas who are 5, 10, even 20+ years post-C-section and still see big improvements with proper techniques

Turbert D